These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 27809808)

  • 1. Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.
    Connelly J; Hormigo A; Mohilie N; Hu J; Chaudhry A; Blondin N
    BMC Cancer; 2016 Nov; 16(1):842. PubMed ID: 27809808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study.
    Chaudhry A; Benson L; Varshaver M; Farber O; Weinberg U; Kirson E; Palti Y
    World J Surg Oncol; 2015 Nov; 13():316. PubMed ID: 26558989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.
    Trusheim J; Dunbar E; Battiste J; Iwamoto F; Mohile N; Damek D; Bota DA; Connelly J
    CNS Oncol; 2017 Jan; 6(1):29-43. PubMed ID: 27628854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
    Stupp R; Taillibert S; Kanner A; Read W; Steinberg D; Lhermitte B; Toms S; Idbaih A; Ahluwalia MS; Fink K; Di Meco F; Lieberman F; Zhu JJ; Stragliotto G; Tran D; Brem S; Hottinger A; Kirson ED; Lavy-Shahaf G; Weinberg U; Kim CY; Paek SH; Nicholas G; Bruna J; Hirte H; Weller M; Palti Y; Hegi ME; Ram Z
    JAMA; 2017 Dec; 318(23):2306-2316. PubMed ID: 29260225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of field strength on glioblastoma multiforme response in patients treated with the NovoTTF™-100A system.
    Turner SG; Gergel T; Wu H; Lacroix M; Toms SA
    World J Surg Oncol; 2014 May; 12():162. PubMed ID: 24884522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor treating fields: a new frontier in cancer therapy.
    Davies AM; Weinberg U; Palti Y
    Ann N Y Acad Sci; 2013 Jul; 1291():86-95. PubMed ID: 23659608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
    Guberina N; Pöttgen C; Kebir S; Lazaridis L; Scharmberg C; Lübcke W; Niessen M; Guberina M; Scheffler B; Jendrossek V; Jabbarli R; Pierscianek D; Sure U; Schmidt T; Oster C; Hau P; Grosu AL; Stuschke M; Glas M; Nour Y; Lüdemann L
    Radiat Oncol; 2020 Apr; 15(1):83. PubMed ID: 32307022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells.
    Giladi M; Munster M; Schneiderman RS; Voloshin T; Porat Y; Blat R; Zielinska-Chomej K; Hååg P; Bomzon Z; Kirson ED; Weinberg U; Viktorsson K; Lewensohn R; Palti Y
    Radiat Oncol; 2017 Dec; 12(1):206. PubMed ID: 29284495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
    Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
    J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
    Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling Tumor Treating fields (TTFields) application within a realistic human head model.
    Wenger C; Salvador R; Basser PJ; Miranda PC
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():2555-8. PubMed ID: 26736813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial.
    Ballo MT; Urman N; Lavy-Shahaf G; Grewal J; Bomzon Z; Toms S
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1106-1113. PubMed ID: 31026557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Treatment for a Patient With a BRAF V600E Mutation Using Dabrafenib and a Tumor Treatment Fields Device in a High-Grade Glioma Arising From Ganglioglioma.
    Meletath SK; Pavlick D; Brennan T; Hamilton R; Chmielecki J; Elvin JA; Palma N; Ross JS; Miller VA; Stephens PJ; Snipes G; Rajaram V; Ali SM; Melguizo-Gavilanes I
    J Natl Compr Canc Netw; 2016 Nov; 14(11):1345-1350. PubMed ID: 27799506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activity of tumor-treating fields in preclinical glioma models.
    Silginer M; Weller M; Stupp R; Roth P
    Cell Death Dis; 2017 Apr; 8(4):e2753. PubMed ID: 28425987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality.
    Wong ET; Lok E; Swanson KD
    Prog Neurol Surg; 2018; 32():180-195. PubMed ID: 29990984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of electrode position for the distribution of tumor treating fields (TTFields) in a human brain. Identification of effective layouts through systematic analysis of array positions for multiple tumor locations.
    Korshoej AR; Hansen FL; Mikic N; von Oettingen G; Sørensen JCH; Thielscher A
    PLoS One; 2018; 13(8):e0201957. PubMed ID: 30133493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: durable response of gliomatosis cerebri with concurrent tumor-treating fields (TTFields) and chemoradiotherapy treatment.
    DesJarlais AM; Miller R; Ali AS; Niazi MZ; Cappelli L; Glass J; Farrell CJ; Shi W
    Chin Clin Oncol; 2023 Dec; 12(6):69. PubMed ID: 38195076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor treating fields for newly diagnosed high-grade glioma based on the criteria of 2021 WHO CNS5: A retrospective analysis of Chinese patients in a single center.
    Zhang L; Ren Y; Peng Y; Luo Y; Liu Y; Wang X; Yang Y; Liu L; Ai P; Yang X; Li Y; Mao Q; Wang F
    Cancer Med; 2024 Jun; 13(11):e7350. PubMed ID: 38859683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
    Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
    Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.